Publication | Closed Access

An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial–mesenchymal transition

MedicineEpithelial–mesenchymal TransitionImmunologyCancer Cell BiologyCancer Lung MetastasisBreast CancerCancer TreatmentRadiation OncologyCancer BiologyCell BiologyLung CancerTumor BiologyTgf-β Type